USPTO Announces COVID-19 Prioritized Examination for Certain Trademark and Service Mark Applications
Updated: Apr 21, 2021
Considering the COVID-19 outbreak and the critical need to develop medical products and services to combat the COVID-19 virus, the United States Patent and Trademark Office (USPTO) has announced a new prioritized examination program for trademark and service mark applications for qualifying COVID-19 related medical products and services.
Generally, the USPTO examines applications in the order of receipt and advances the examination of an application out of turn in very special circumstances. The USPTO has termed the COVID-19 outbreak an “extraordinary situation.”
To avail to prioritized examination under this initiative, an applicant must seek registration for qualifying COVID-19 related services or COVID-19 related medical products that are subject to approval by the United States Food and Drug Administration. The applicant must first file the application and then file a Petition to the Director with a statement of facts explaining why the good or service qualifies for prioritized examination. The USPTO is waiving the fee under this program.
Detailed information about the “Prioritized Examination Program” can be found at:
Please contact us if you are interested in more information.